Eivor Örnskov, Ph.D.Associate Principal Scientist, Pharmaceutical at AstraZeneca Gothenburg
Dr. Eivor Örnskov received a PhD in Analytical Chemistry in 2004 from Uppsala University, Sweden. At AstraZeneca Gothenburg Sweden, Eivor has developed numerous stability indicating Liquid Chromatography and Capillary Electrophoresis methods for use in pre-clinical and clinical phase. In her current position, Eivor is responsible for development of the analytical platform for large RNA and coordinate the analytical contributions in clinical mRNA projects within AstraZeneca Gothenburg. Furthermore, Eivor has written CMC parts of regulatory submissions and published research papers in the area of polynucleotide and mRNA separations.